WallStreetZen

NASDAQ: AVGR
Avinger Inc Stock Forecast, Predictions & Price Target

Analyst price target for AVGR

Based on 2 analysts offering 12 month price targets for Avinger Inc.
Min Forecast
$2.50+203.4%
Avg Forecast
$2.50+203.4%
Max Forecast
$2.50+203.4%

Should I buy or sell AVGR stock?

Based on 2 analysts offering ratings for Avinger Inc.
Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

AVGR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Anonymous
B. Riley Securities
Strong BuyInitiates Coverage On$2.50+203.40%2021-06-29
Aegis Capital
Bottom 42%
42
Strong BuyMaintains$2.50+203.40%2021-01-19

1 of 1

Forecast return on equity

Is AVGR forecast to generate an efficient return?
Company
-104.83%
Industry
22.99%
Market
1,975.19%
AVGR's Return on Equity is forecast to be low in 3 years (-104.83%); analysts are not confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is AVGR forecast to generate an efficient return on assets?
Company
-47.44%
Industry
11.68%
Market
951.37%
AVGR is forecast to generate lower Return on Assets (-47.44%) than the US Medical Devices industry average (11.68%)
Forecast

AVGR earnings per share forecast

What is AVGR's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$0.23+21.05%
Avg 2 year Forecast
-$0.23+21.05%
Avg 3 year Forecast
-$0.19+0%

AVGR revenue forecast

What is AVGR's revenue in the next 3 years based on estimates from 1 analysts?
Avg 1 year Forecast
$11.2M+7.77%
Avg 2 year Forecast
$15.7M+50.75%
Avg 3 year Forecast
$21.8M+110.1%
AVGR's revenue is forecast to grow at an exceptional rate of 24.98% per year
Forecast

AVGR revenue growth forecast

How is AVGR forecast to perform vs Medical Devices companies and vs the US market?
Company
24.98%
Industry
7.89%
Market
14.64%
AVGR's revenues are forecast to grow faster (24.98% per year) than the US Medical Devices industry average (7.89%)
Forecast
AVGR's revenues are forecast to grow faster (24.98% per year) than the US market average (14.64%)
Forecast

Avinger Stock Forecast FAQ

Is Avinger Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: AVGR) stock is to Strong Buy AVGR stock.

Out of 2 analysts, 2 (100%) are recommending AVGR as a Strong Buy, 0 (0%) are recommending AVGR as a Buy, 0 (0%) are recommending AVGR as a Hold, 0 (0%) are recommending AVGR as a Sell, and 0 (0%) are recommending AVGR as a Strong Sell.

What is AVGR's earnings growth forecast for 2021-2023?

(NASDAQ: AVGR) Avinger's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 36.72%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 22.98%.

Avinger's earnings in 2021 is -$20,679,000.On average, 2 Wall Street analysts forecast AVGR's earnings for 2021 to be $-21,931,190, with the lowest AVGR earnings forecast at $-21,931,190, and the highest AVGR earnings forecast at $-21,931,190. On average, 2 Wall Street analysts forecast AVGR's earnings for 2022 to be $-21,931,190, with the lowest AVGR earnings forecast at $-21,931,190, and the highest AVGR earnings forecast at $-20,977,660.

In 2023, AVGR is forecast to generate $-18,117,070 in earnings, with the lowest earnings forecast at $-18,117,070 and the highest earnings forecast at $-18,117,070.

What is AVGR's revenue growth forecast for 2021-2023?

(NASDAQ: AVGR) Avinger's forecast annual revenue growth rate of 24.98% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.89%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 14.64%.

Avinger's revenue in 2021 is $10,395,000.On average, 1 Wall Street analysts forecast AVGR's revenue for 2021 to be $1,068,239,681, with the lowest AVGR revenue forecast at $1,068,239,681, and the highest AVGR revenue forecast at $1,068,239,681. On average, 1 Wall Street analysts forecast AVGR's revenue for 2022 to be $1,494,181,541, with the lowest AVGR revenue forecast at $1,494,181,541, and the highest AVGR revenue forecast at $1,494,181,541.

In 2023, AVGR is forecast to generate $2,082,509,564 in revenue, with the lowest revenue forecast at $2,082,509,564 and the highest revenue forecast at $2,082,509,564.

What is AVGR's forecast return on assets (ROA) for 2021-2023?

(NASDAQ: AVGR) forecast ROA is -47.44%, which is lower than the forecast US Medical Devices industry average of 11.68%.

What is AVGR's Price Target?

According to 2 Wall Street analysts that have issued a 1 year AVGR price target, the average AVGR price target is $2.50, with the highest AVGR stock price forecast at $2.50 and the lowest AVGR stock price forecast at $2.50.

On average, Wall Street analysts predict that Avinger's share price could stay at $2.50 by Jun 29, 2022. The average Avinger stock price prediction forecasts a potential downside of N/A from the current AVGR share price of $0.82.

What is AVGR's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: AVGR) Avinger's current Earnings Per Share (EPS) is -$0.19. On average, analysts forecast that AVGR's EPS will be $-0.23 for 2021, with the lowest EPS forecast at $-0.23, and the highest EPS forecast at $-0.23. On average, analysts forecast that AVGR's EPS will be $-0.23 for 2022, with the lowest EPS forecast at $-0.23, and the highest EPS forecast at $-0.22. In 2023, AVGR's EPS is forecast to hit $-0.19 (min: $-0.19, max: $-0.19).

What is AVGR's forecast return on equity (ROE) for 2021-2023?

(NASDAQ: AVGR) forecast ROE is -104.83%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.